2009年7月28日委员会决定,修订有关用于传统草药药品的草药、配制品以及化合物的清单(在文件C(2009) 5804中通报)
技术法规类型:欧盟Eurlex法规 来源:tbtmap
EURLEX ID:32010D0028
OJ编号:OJ L 11, 16.1.2010, p. 12-18
中文标题:2009年7月28日委员会决定,修订有关用于传统草药药品的草药、配制品以及化合物的清单(在文件C(2009) 5804中通报)
原文标题:Commission Decision of 28 July 2009 amending the list of herbal substances, preparations and combinations thereof for use in traditional herbal medicinal products (notified under document C(2009) 5804) (Text with EEA relevance)
分类:13.30.15_医药产品
文件类型:二级立法 Decision|决定
废止日期:2058-12-31
法规全文:查看欧盟官方文件
32010D0028
Title and reference
Commission Decision of 28 July 2009 amending the list of herbal substances, preparations and combinations thereof for use in traditional herbal medicinal products (notified under document C(2009) 5804) (Text with EEA relevance)
?OJ L 11, 16.1.2010, p. 12–18 (BG, ES, CS, DA, DE, ET, EL, EN, FR, IT, LV, LT, HU, MT, NL, PL, PT, RO, SK, SL, FI, SV)
?BG?CS?DA?DE?EL?EN?ES?ET?FI?FR?HU?IT?LT?LV?MT?NL?PL?PT?RO?SK?SL?SV
Text
| BG | ES | CS | DA | DE | ET | EL | EN | FR | GA | IT | LV | LT | HU | MT | NL | PL | PT | RO | SK | SL | FI | SV |
| html | html | html | html | html | html | html | html | html | ? | html | html | html | html | html | html | html | html | html | html | html | html | html |
| ? | ||||||||||||||||||||||
| tiff | tiff | tiff | tiff | tiff | tiff | tiff | tiff | tiff | tiff | tiff | tiff | tiff | tiff | tiff | tiff | tiff | tiff | tiff | tiff | tiff | tiff | tiff |
Dates
- of document: 28/07/2009
of notification: 00/00/0000
of effect: 00/00/0000; Entry into force Date notif.
end of validity: 99/99/9999
Classifications
- EUROVOC descriptor:
crop production
pharmaceutical industry
medicament
medical plant - Directory code:
13.30.15.00 Industrial policy and internal market / Internal market: approximation of laws / Proprietary medicinal products
- Subject matter:
Approximation of laws, Internal market, Health protection
Miscellaneous information
- Author:
European Commission - Form:
Decision - Addressee:
Member States of the Community - Additional information:
EEA relevance
Relationship between documents
- Treaty:
European Community - Legal basis:
32001L0083 -A16PTF)
- Select all documents based on this document
- Amendment to:
32008D0911 Amendment Amendment Annex 1 from /F/DATE
32008D0911 Amendment Amendment Annex 2 from /F/DATE
- Select all documents mentioning this document
Text
| Bilingual display: BG CS DA DE EL EN ES ET FI FR HU IT LT LV MT NL PL PT RO SK SL SV |
Commission Decision
of 28 July 2009
amending the list of herbal substances, preparations and combinations thereof for use in traditional herbal medicinal products
(notified under document C(2009) 5804)
(Text with EEA relevance)
(2010/28/EC)
THE COMMISSION OF THE EUROPEAN COMMUNITIES,
Having regard to the Treaty establishing the European Community,
Having regard to Directive 2001/83/EC of the European Parliament and of the Council of 6 November 2001 on the Community code relating to medicinal products for human use [1], and in particular Article 16(f) thereof,
Having regard to the opinions of the European Medicines Agency, formulated on 10 January 2008 and 6 March 2008 by the Committee for Herbal Medicinal Products,
Whereas:
(1) Calendula officinalis L and Pimpinella anisum L comply with the requirements set out in Directive 2001/83/EC. Calendula officinalis L and Pimpinella anisum L can be considered as herbal substances, herbal preparations or combinations thereof.
(2) It is therefore appropriate to include Calendula officinalis L and Pimpinella anisum L in the list of herbal substances, preparations and combinations thereof for use in traditional herbal medicinal products established in Annex I to Commission Decision 2008/911/EC [2].
(3) Decision 2008/911/EC should therefore be amended accordingly.
(4) The measures provided for in this Decision are in accordance with the opinion of the Standing Committee on Medicinal Products for Human Use,
HAS ADOPTED THIS DECISION:
Article 1
Decision 2008/911/EC is amended as follows:
1. Annex I is amended in accordance with Annex I to this Decision.
2. Annex II is amended in accordance with Annex II to this Decision.
Article 2
This Decision is addressed to the Member States.
Done at Brussels, 28 July 2009.
For the Commission
Günter Verheugen
Vice-President
[1] OJ L 311, 28.11.2001, p. 67.
[2] OJ L 328, 6.12.2008, p. 42.
--------------------------------------------------
ANNEX I
In Annex I to Decision 2008/911/EC, the following is inserted:
- "Calendula officinalis L" is inserted before Foeniculum vulgare Miller subsp. vulgare var. vulgare (Bitter fennel, fruit),
- "Pimpinella anisum L" is inserted after Foeniculum vulgare Miller subsp. vulgare var. dulce (Miller) Thellung (Sweet fennel, fruit).
--------------------------------------------------
ANNEX II
In Annex II to Decision 2008/911/EC, the following is inserted:
- "Calendula officinalis L" is inserted before Foeniculum vulgare Miller subsp. vulgare var. vulgare (Bitter fennel, fruit)
"COMMUNITY LIST ENTRY ON CALENDULA OFFICINALIS L
Scientific name of the plant
Calendula officinalis L.
Botanical family
Asteraceae
Herbal substance
Calendula flower
Common name in all EU official languages of herbal substance
BG (b?lgarski): Невен, цвят
CS (?e?tina): Měsí?kov? květ
DA (dansk): Morgenfrueblomst
DE (Deutsch): Ringelblumenblüten
EL (elliniká): ?νθο? καλ?ντουλα?
EN (English): Calendula flower
ES (espa?ol): Flor de caléndula
ET (eesti keel): Saialille?isik
FI (suomi): Tarhakeh?kukan kukka
FR (fran?ais): Souci
HU (magyar): A k?r?mvirág virága
IT (italiano): Calendula fiore
LT (lietuvi? kalba): Medetk? ?iedai
LV (latvie?u valoda): Kli??erītes ziedi
MT (malti): Fjura calendula
NL (nederlands): Goudsbloem
PL (polski): Kwiat nagietka
PT (português): Flor de calêndula
RO (rom?n?): Floare de g?lbenele (calendula)
SK (sloven?ina): Nechtíkov? kvet
SL (sloven??ina): Cvet vrtnega ognji?a
SV (svenska): Ringblomma, blomma
IS (íslenska): Morgunfrú, blóm
NO (norsk): Ringblomst
Herbal preparation(s)
A. Liquid extract (DER 1:1), extraction solvent ethanol 40-50 % (v/v).
B. Liquid extract (DER 1:1,8-2,2), extraction solvent ethanol 40-50 % (v/v).
C. Tincture (DER 1:5), extraction solvent ethanol 70-90 % (v/v).
European Pharmacopoeia monograph reference
Calendula flower – Calendulae flos (01/2005:1297)
Indication(s)
(a) Traditional herbal medicinal product for the symptomatic treatment of minor inflammations of the skin (such as sunburn) and as an aid in healing of minor wounds.
(b) Traditional herbal medicinal product for the symptomatic treatment of minor inflammations in the mouth or the throat.
The product is a traditional herbal medicinal product for use in specified indications exclusively based upon long-standing use.
Type of tradition
European
Specified strength
Please see "Specified posology".
Specified posology
Herbal preparations:
A. Liquid extract (DER 1:1)
In semi-solid dosage forms: amount equivalent to 2-10 % herbal substance.
B. Liquid extract (DER 1:1,8-2,2)
In semi-solid dosage forms: amount equivalent to 2-5 % herbal substance.
C. Tincture (DER 1:5)
In compresses diluted at least 1:3 with freshly boiled water.
In semi-solid dosage forms: amount equivalent to 2-10 % herbal substance.
As a gargle or mouth rinse in a 2 % solution.
2 to 4 times daily
Indication (a)
The use is not recommended in children under 6 years of age (see below "Special warnings and precautions for use").
Indication (b)
The use in children under 12 years of age is not recommended because there is no experience available (see below "Special warnings and precautions for use").
Route of administration
Cutaneous and oromucosal use.
Duration of use or any restrictions on the duration of use
Compresses: remove after 30-60 minutes
All herbal preparations: If the symptoms persist after 1 week during the use of the medicinal product a doctor or a qualified health care practitioner should be consulted.
Any other information necessary for the safe use
Contraindications
Hypersensitivity to members of the Asteraceae (Compositae) family.
Special warnings and precautions for use
Indication (a)
The use in children under 6 years of age is not recommended because there is no experience available.
Indication (b)
The use in children under 12 years of age is not recommended because there is no experience available.
If signs of skin infection are observed, a doctor or a qualified health care practitioner should be consulted.
Interactions with other medicinal products and other forms of interaction
None reported.
Pregnancy and lactation
Safety during pregnancy and lactation has not been established.
In the absence of sufficient data, the use during pregnancy and lactation is not recommended.
Effects on ability to drive and use machines
Not relevant.
Undesirable effects
Skin sensitisation. The frequency is not known.
If other adverse reactions not mentioned above occur, a doctor or a qualified health care practitioner should be consulted.
Overdose
None reported."
- "Pimpinella anisum L" is inserted after Foeniculum vulgare Miller subsp. vulgare var. dulce (Miller) Thellung (Sweet fennel, fruit)
"COMMUNITY LIST ENTRY ON PIMPINELLA ANISUM L
Scientific name of the plant
Pimpinella anisum L.
Botanical family
Apiaceae
Herbal substance
Aniseed
Common name in all EU official languages of herbal substance
BG (b?lgarski): Анасон, плод
CS (?e?tina): An?zov? plod
DA (dansk): Anisfr?
DE (Deutsch): Anis
EL (elliniká): Γλυκ?νισο
EN (English): Aniseed
ES (espa?ol): Fruto de anís
ET (eesti keel): Aniis
FI (suomi): Anis
FR (fran?ais): Anis (fruit d)
HU (magyar): ?nizsmag
IT (italiano): Anice (Anice verde), frutto
LT (lietuvi? kalba): Any?i? s?klos
LV (latvie?u valoda): Anīsa sēklas
MT (malti): Frotta tal-Anisi
NL (nederlands): Anijsvrucht
PL (polski): Owoc any?u
PT (português): Anis
RO (rom?n?): Fruct de anason
SK (sloven?ina): Anízov? plod
SL (sloven??ina): Plod vrtnega jane?a
SV (svenska): Anis
IS (íslenska): Anís
NO (norsk): Anis
Herbal preparation(s)
Dried aniseed, comminuted or crushed
European Pharmacopoeia monograph reference
Anisi fructus (01/2005:0262)
Indication(s)
(a) Traditional herbal medicinal product for symptomatic treatment of mild, spasmodic gastro-intestinal complaints including bloating and flatulence.
(b) Traditional herbal medicinal product used as an expectorant in cough associated with cold.
The product is a traditional herbal medicinal product for use in specified indications exclusively based upon long-standing use.
Type of tradition
European
Specified strength
Please see "Specified posology"
Specified posology
Adolescents over 12 years of age, adults, elderly:
Indications (a) and (b)
1 to 3,5 g of whole or (freshly [*]) comminuted or crushed aniseed in 150 ml of boiling water as a herbal tea
3 times daily
The use in children under 12 years is not recommended of age (see below "Special warnings and precautions for use").
Route of administration
Oral use
Duration of use or any restrictions on the duration of use
Not to be taken for more than 2 weeks.
If the symptoms persist during the use of the medicinal product, a doctor or a qualified health care practitioner should be consulted.
Any other information necessary for the safe use
Contraindications
Hypersensitivity to the active substance or to Apiaceae (Umbelliferae) (caraway, celery, coriander, dill and fennel) or to anethole.
Special warnings and precautions for use
The use is not recommended in children under 12 years of age due to the lack of adequate data for safety assessment.
Interactions with other medicinal products and other forms of interaction
None reported.
Pregnancy and lactation
There are no data from the use of aniseed in pregnant patients.
It is unknown if aniseed constituents are excreted in human breast milk.
In the absence of sufficient data, the use during pregnancy and lactation is not recommended.
Effects on ability to drive and use machines
No studies on the effect on the ability to drive and use machines have been performed.
Undesirable effects
Allergic reactions to aniseed affecting the skin or the respiratory system may occur. The frequency is not known.
If other adverse reactions not mentioned above occur, a doctor or a qualified health care practitioner should be consulted.
Overdose
No case of overdose has been reported.
[*] For commercial preparations of comminuted or crushed aniseed the applicant must carry out appropriate stability testing related to the content of essential oil components."
--------------------------------------------------
| Top |
托管标准,您可以接收以下服务:
1 标准定期系统查新,若有最新版本,会以站内短信或邮件的形式通知用户;
2 随时在标准托管页面中查看到该条标准的最新状态;
3 若用户有在学习和科研中的需要,可以在标准托管页面中试阅标准;
4 企业如果需要上新产品,我院及时提供标准查询、采购等方面的支持;
5 为企业在标准制修订、企业良好行为创建以及标准化试点过程中遇到的困难,可联系我院指定相关专家负责进行指导帮助、提供政策咨询;
6 为企业提供标准化政策的解读、标准化知识的推广培训、标准自我公开声明、标准文献的免费查询、企业标准化体系建设等方面的标准化服务;
标准资讯点击排行榜 全部
资讯标题点击
[[ n.title ]] [[ n.read ]]大连标准化公共服务平台
版权:大连标准化研究院有限公司
地址:大连市中山区高原街56号
电话:0411-82740851